Dalarada Health, Biotech Stock Review

Dalrada Cervical Cancer Testing Kit Study.

KEY TAKEAWAYS Dalrada Corp (DFCO) LIVE QUOTE
biotech stock review

Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’ Smear Test Screening.

DALRADA aims to introduce its VIA Test kit to females in India - of which there is 497 million.
Issam Radd

Citius Pharma (CTXR) Shareholder Letter | Year Ahead Roadmap.

2021 and 2020 Milestones In Plain Sight. Locked and Loaded for most of 2020 - many major milestone...

Citius Pharma (CTXR) Video Presentation.

Chairman Leonard Mazur Discusses: Mino-Lok Treatment for Infected Catheters. Novellus Stem Cell Treatment...

Mitesco Inc. Initiates “The Good Clinic” Rollout in Minneapolis; Introduces the Founders of “The...

MINNEAPOLIS, MN, Sept. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Mitesco, Inc. (OTCQB: MITI) today announced that The Good Clinic, LLC has filed...
American BriVision

American BriVision’s (ABVC) Clinical Study Sparks Interest From Potential Partners.

Is Wall Street Missing American Brivision's Full Clinical Safety and Efficacy Study? We Think it has. Potential...

There’s Simply No Loyalty Anymore.

TODAY'S LETTER Frontier Bio (FBIO) $3.90. We Have Another Double! American BriVision (ABVC) $4.00. Wait, What? Yet...
Roland Rick Perry, Biotech Stock Review, Frontier Bio

And We Have Another Double. Frontier Bio (FBIO) Crosses $4.00.

Sometimes we Can't Beleive Our Luck Over the Last Couple Years. But There You Have it, at Least we Know It's...
citius pharma, biotech stock review

Investors Bet $8 Million on Citius Pharma (CTXR) $1.10, Succeeding in FDA Trials!

Great headline, right? The actual headline was: Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering to $8.4 Million
American Brivision

Adding American BriVision (ABVC) $3.30 to Stocks We Expect Double List. $7.00 Price Potential.

Adding to Our 2020 Biotech 5-Pack, 5 Stocks We Expect to Double in 2020

Latest article

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...

Major Mpox Outbreak in the Democratic Republic of Congo.

As Reported in NPR's Gates and Soda Major Mpox Outbreak in the Democratic Republic of Congo is a...

Mpox Infections Rise to Almost Double Last Year’s Numbers.

The number of mpox cases in 2024 is already nearly double the number of cases that were detected in all of...